Standout Papers

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, an... 2023 2026 2024153
  1. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants (2023)
    Chad Bousman, James M. Stevenson et al. Clinical Pharmacology & Therapeutics

Immediate Impact

58 standout
Sub-graph 1 of 20

Citing Papers

ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment
2024 Standout
Attention-deficit/hyperactivity disorder
2024 Standout
2 intermediate papers

Works of Jacob T. Brown being referenced

Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy
2019
Atomoxetine Pharmacogenetics: Associations with Pharmacokinetics, Treatment Response and Tolerability
2015

Author Peers

Author Last Decade Papers Cites
Jacob T. Brown 244 330 134 137 36 685
Pablo Zubiaur 153 319 160 93 71 817
Josiah D. Allen 222 570 274 309 18 841
Jesús Novalbos 91 209 165 116 45 758
Gina Mejía‐Abril 122 252 101 67 50 612
Joel G Winner 220 562 263 326 13 792
Emmanuelle Bondon‐Guitton 116 72 95 142 47 797
Jeffrey Paul 133 169 188 233 29 684
Yow‐Wen Hsieh 187 131 145 78 40 758
Richard A. Okerholm 87 191 59 169 36 830
Gary A. Pritchard 109 165 46 77 31 711

All Works

Loading papers...

Rankless by CCL
2026